Chavda S*

Department of Orthopedics, RAK Medical and Health Sciences University, Ras al Khaimah, United Arab Emirates

*Corresponding Author: Chavda S, Department of Orthopedics, RAK Medical and Health Sciences University, Ras al Khaimah, United Arab Emirates.

Received: December 23, 2022; Published: February 03, 2023

Abstract

Osteoporosis is a chronic condition that causes bone fragility fractures and is a major public health issue worldwide [1]. According to the Scorecard for Osteoporosis in Europe (SCORE), the prevalence and burden of osteoporosis are expected to rise over the next 10 years, primarily as a result of population aging. According to the estimates, more than 30 million people in Europe and a comparable number of individuals in the United States suffer with osteoporosis [2]. The availability of the standard dual-energy X-ray absorptiometry (DXA), which has been adopted in the majority of western countries but is still underutilized in many other developing countries is strictly correlated with the prevalence of osteoporosis [3]. Osteoporosis is a societal burden brought on by both individual and environmental factors.

References

1. Adami G., et al. “Osteoporosis in 10 years’ time: a glimpse into the future of osteoporosis”. Therapeutic Advances in Musculoskeletal Disease 14 (2022): 1759720X221083541.
2. Wright NC., et al. “The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine”. Journal of Bone and Mineral Research 11 (2014): 2520-2526.
3. Khashayar P., et al. “Osteoporosis strategic plan for the Middle East and North Africa region”. Archives of Osteoporosis 1 (2019): 20.
4. Kanis JA., et al. “The diagnosis of osteoporosis. Journal of Bone and Mineral Research 8 (2009): 1137-1141.
5. Johnell O and Kanis JA. “An estimate of the worldwide prevalence and disability associated with osteoporotic fractures”. Osteoporosis International 12 (2016): 1726-1733.
6. Kanis JA., et al. “FRAX Update”. Journal of Clinical Densitometry 3 (2017): 360-367.
7. NIH Consensus Development Panel on Osteoporosis Prevention D and T. Osteoporosis prevention, diagnosis, and therapy”. JAMA6 (2001): 785-795.
8. Martineau P., et al. “In which patients does lumbar spine trabecular bone score (TBS) have the largest effect?” Bone 113 (2018): 161-168.
9. McCloskey EV., et al. “A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX”. Journal of Bone and Mineral Research 5 (2015): 940-948.
10. Leslie WD., et al. “Hip axis length is a FRAX- and bone density-independent risk factor for hip fracture in women”. The Journal of Clinical Endocrinology and Metabolism 5 (2015): 2063-2070.
11. Beck TJ., et al. “Predicting femoral neck strength from bone mineral data. A structural approach”. Investigative Radiology 1 (1990): 6-18.
12. Khoo BCC., et al. “Evaluation of a simplified hip structure analysis method for the prediction of incident hip fracture events”. Osteoporosis International 1 (2016): 241-248.
13. Viceconti M., et al. “Are CT-Based Finite Element Model Predictions of Femoral Bone Strength Clinically Useful?” Current Osteoporosis Reports 3 (2018): 216-223.
14. Di Paola M., et al. “Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck”. Osteoporosis International 2 (2019): 391-402.
15. Adami G., et al. “Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study”. Bone 134 (2020): 115297.
16. Diez-Perez A., et al. “Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)”. Aging Clinical and Experimental Research 10 (2019): 1375-1389.
17. Samelson EJ., et al. “Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study”. Lancet Diabetes Endocrinology 1 (2019): 34-43.

Citation

Citation: Chavda S. “Osteoporosis Diagnosis and Assessment: What is in the Future?”.Acta Scientific Orthopaedics 6.3 (2023): 21-23.

Copyright

Copyright: © 2023 Chavda S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.